98 related articles for article (PubMed ID: 28273003)
41. Where are the men? Targeting male partners in preventing mother-to-child HIV transmission.
Koo K; Makin JD; Forsyth BW
AIDS Care; 2013; 25(1):43-8. PubMed ID: 22670795
[TBL] [Abstract][Full Text] [Related]
42. Assessing male spousal engagement with prevention of mother-to-child transmission (pMTCT) programs in western Kenya.
Reece M; Hollub A; Nangami M; Lane K
AIDS Care; 2010 Jun; 22(6):743-50. PubMed ID: 20461572
[TBL] [Abstract][Full Text] [Related]
43. Young Women's Ratings of Three Placebo Multipurpose Prevention Technologies for HIV and Pregnancy Prevention in a Randomized, Cross-Over Study in Kenya and South Africa.
Minnis AM; Roberts ST; Agot K; Weinrib R; Ahmed K; Manenzhe K; Owino F; van der Straten A;
AIDS Behav; 2018 Aug; 22(8):2662-2673. PubMed ID: 29560570
[TBL] [Abstract][Full Text] [Related]
44. "You tell him that 'baby, I am protecting myself'": Women's agency and constraint around willingness to use pre-exposure prophylaxis in the Masibambane Study.
Harrison A; Bhengu N; Miller L; Exner T; Tesfay N; Magutshwa S; Khumalo S; Bergam S; Hoffman S; Hanass-Hancock J
Womens Health (Lond); 2022; 18():17455057221087117. PubMed ID: 35306944
[TBL] [Abstract][Full Text] [Related]
45. Prevalence and correlates of willingness to participate in a rectal microbicide trial among men who have sex with men in Bangkok.
Thienkrua W; Todd CS; Chaikummao S; Sukwicha W; Yafant S; Tippanont N; Varangrat A; Khlaimanee P; Holtz TH
AIDS Care; 2014; 26(11):1359-69. PubMed ID: 24797186
[TBL] [Abstract][Full Text] [Related]
46. Gender relations in the context of HIV/AIDS in rural South Africa.
Ndinda C; Uzodike UO; Chimbwete C; Pool R;
AIDS Care; 2007 Aug; 19(7):844-9. PubMed ID: 17712686
[TBL] [Abstract][Full Text] [Related]
47. Gender power imbalance on women's capacity to negotiate self-protection against HIV/AIDS in Botswana and South Africa.
Langen TT
Afr Health Sci; 2005 Sep; 5(3):188-97. PubMed ID: 16245988
[TBL] [Abstract][Full Text] [Related]
48. Changes in sexual behavior during a safety and feasibility trial of a microbicide/diaphragm combination: an integrated qualitative and quantitative analysis.
Guest G; Johnson L; Burke H; Rain-Taljaard R; Severy L; von Mollendorf C; Van Damme L
AIDS Educ Prev; 2007 Aug; 19(4):310-20. PubMed ID: 17685844
[TBL] [Abstract][Full Text] [Related]
49. Expanding the relationship context for couple-based HIV prevention: Elucidating women's perspectives on non-traditional sexual partnerships.
Crankshaw TL; Voce A; Butler LM; Darbes L
Soc Sci Med; 2016 Oct; 166():169-176. PubMed ID: 27566046
[TBL] [Abstract][Full Text] [Related]
50. Perceived influence of an HIV vaccine on sexual-risk behaviour in the Dominican Republic.
Barrington C; Moreno L; Kerrigan D
Cult Health Sex; 2008 May; 10(4):391-401. PubMed ID: 18484381
[TBL] [Abstract][Full Text] [Related]
51. Community Perceptions About Use of Pre-exposure Prophylaxis Among Adolescent Girls and Young Women in Kenya.
Escudero JN; Dettinger JC; Pintye J; Kinuthia J; Lagat H; Abuna F; Kohler P; Baeten JM; OʼMalley G; John-Stewart GC; Beima-Sofie KM
J Assoc Nurses AIDS Care; 2020; 31(6):669-677. PubMed ID: 32675642
[TBL] [Abstract][Full Text] [Related]
52. Empowering Women or Pleasing Men? Analyzing Male Views on Female Condom Use in Zimbabwe, Nigeria and Cameroon.
Koster W; Bruinderink MG; Janssens W
Int Perspect Sex Reprod Health; 2015 Sep; 41(3):126-35. PubMed ID: 26600566
[TBL] [Abstract][Full Text] [Related]
53. Indian married men's interest in microbicide use.
Kohli R; Tsui S; Mehendale S; Tolley E
AIDS Care; 2011 Oct; 23(10):1344-9. PubMed ID: 21711169
[TBL] [Abstract][Full Text] [Related]
54. Acceptability and preferences for safer conception HIV prevention strategies: a qualitative study.
Schwartz SR; West N; Phofa R; Yende N; Sanne I; Bassett J; Van Rie A
Int J STD AIDS; 2016 Oct; 27(11):984-92. PubMed ID: 26384950
[TBL] [Abstract][Full Text] [Related]
55. Health practices and vaginal microbicide acceptability among urban black women.
Reiff M; Wade C; Chao MT; Kronenberg F; Cushman LF
J Womens Health (Larchmt); 2008 Oct; 17(8):1345-51. PubMed ID: 18788991
[TBL] [Abstract][Full Text] [Related]
56. Microbicides are promoted as offering a 'female-controlled' HIV prevention method: so can they revolutionize the HIV crisis of young women in Kenya?
Raphael MC
J Public Health (Oxf); 2012 Dec; 34(4):625-30. PubMed ID: 23055541
[No Abstract] [Full Text] [Related]
57. Sexual pleasure, gender power and microbicide acceptability in Zimbabwe and Malawi.
Woodsong C; Alleman P
AIDS Educ Prev; 2008 Apr; 20(2):171-87. PubMed ID: 18433322
[TBL] [Abstract][Full Text] [Related]
58. Combinatorial prevention of HIV transmission in women: the case for a vaginal microbicide.
Bélec L; Jenabian MA; Charpentier C; Saïdi H
Future Microbiol; 2011 Jul; 6(7):731-7. PubMed ID: 21797688
[TBL] [Abstract][Full Text] [Related]
59. Attitudes of men in an Australian male tolerance study towards microbicide use.
Holmes WR; Maher L; Rosenthal SL
Sex Health; 2008 Sep; 5(3):273-8. PubMed ID: 18771643
[TBL] [Abstract][Full Text] [Related]
60. Understanding the role of men in women's use of the vaginal ring and oral PrEP during pregnancy and breastfeeding: multi-stakeholder perspectives.
Musara P; Hartmann M; Ryan JH; Reddy K; Ggita J; Mutero P; Macagna N; Taulo F; Mgodi NM; Piper J; van der Straten A
Afr J AIDS Res; 2022 Dec; 21(4):354-363. PubMed ID: 36538544
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
